Generali Asset Management’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.64M Buy
40,735
+10,976
+37% +$768K 0.07% 229
2026
Q1
$3.12M Sell
29,759
-17,262
-37% -$1.23M 0.07% 242
2025
Q4
$3.98M Buy
47,021
+19,369
+70% +$1.14M 0.08% 212
2025
Q3
$2.26M Buy
27,652
+862
+3% +$50.2K 0.05% 284
2025
Q2
$2.13M Buy
26,790
+6,838
+34% +$386K 0.05% 295
2025
Q1
$1.42M Buy
19,952
+2,271
+13% +$116K 0.04% 357
2024
Q4
$1.14M Buy
+17,681
New +$839K 0.03% 357

Other funds holding NTR

Generali Asset Management's NTR Position: Q2 2026 in Review

Generali Asset Management increased its Nutrien (NTR) stake by 37% in Q2 2026, buying an estimated $768K and bringing the position to 40,735 shares worth $3.64M. The position accounts for 0.07% of the portfolio, ranked #229.

Generali Asset Management first reported a position in NTR in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.98M in Q4 2025. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Generali Asset Management held 40,735 shares of Nutrien worth $3.64M as of Q2 2026.
  • Generali Asset Management bought 10,976 Nutrien shares in Q2 2026, an estimated $768K.
  • Nutrien made up 0.07% of Generali Asset Management's portfolio in Q2 2026, its #229 holding.
  • Generali Asset Management first reported a position in Nutrien in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Nutrien position peaked at $3.98M in Q4 2025.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.